Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov;396(11):2843-2860.
doi: 10.1007/s00210-023-02537-y. Epub 2023 Jun 20.

Research progress on pharmacological effects and mechanisms of cepharanthine and its derivatives

Affiliations
Review

Research progress on pharmacological effects and mechanisms of cepharanthine and its derivatives

Liangliang Shi et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov.

Abstract

Cepharanthine (CEP) is a bisbenzylisoquinoline alkaloid compound found in plants of the Stephania genus, which has biological functions such as regulating autophagy, inhibiting inflammation, oxidative stress, and apoptosis. It is often used for the treatment of inflammatory diseases, viral infections, cancer, and immune disorders and has great clinical translational value. However, there is no detailed research on its specific mechanism and dosage and administration methods, especially clinical research is limited. In recent years, CEP has shown significant effects in the prevention and treatment of COVID-19, suggesting its potential medicinal value waiting to be discovered. In this article, we comprehensively introduce the molecular structure of CEP and its derivatives, describe in detail the pharmacological mechanisms of CEP in various diseases, and discuss how to chemically modify and design CEP to improve its bioavailability. In summary, this work will provide a reference for further research and clinical application of CEP.

Keywords: Anti-inflammatory; Antitumor; Antiviral; Cepharanthine; Derivatives; Immunity; Molecular mechanism.

PubMed Disclaimer

References

    1. Al-Humadi HW, Al-Saigh RJ, Al-Humadi AW (2017) Addressing the challenges of tuberculosis: a brief historical account. Front Pharmacol 8:689 - PubMed - PMC - DOI
    1. Anwanwan D, Singh SK, Singh S et al (2020) Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer 1873(1):188314 - PubMed - DOI
    1. Bailly C (2019) Cepharanthine: an update of its mode of action, pharmacological properties and medical applications. Phytomedicine 62:152956 - PubMed - PMC - DOI
    1. Biospace (n.d.) Pharmadrug announces successful completion of PreIND meeting with FDA regarding proposed development of its cepharanthine for treatment of mild to moderate COVID-19 infection. https://www.newsfilecorp.com/release/105841.2021 .
    1. Brown GC, Neher JJ (2010) Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 41(2–3):242–247 - PubMed - DOI

Publication types

LinkOut - more resources